| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Return On Equity | 39.2 | % | -28.5% |
| Return On Assets | -1.03K | % | -38.2% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Entity Common Stock, Shares Outstanding | 297M | shares | +372% |
| Entity Public Float | 491K | USD | -72.5% |
| Common Stock, Value, Issued | 297K | USD | +372% |
| Weighted Average Number of Shares Outstanding, Basic | 297M | shares | +372% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Revenues | 0 | USD | -100% |
| Research and Development Expense | 44.6K | USD | -65.4% |
| General and Administrative Expense | 151K | USD | -25.7% |
| Net Income (Loss) Attributable to Parent | -697K | USD | +23.4% |
| Earnings Per Share, Basic | 0 | USD/shares |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | 30.7K | USD | +18.4% |
| Other Assets, Current | 1.85K | USD | -56.6% |
| Assets, Current | 41.3K | USD | -19% |
| Property, Plant and Equipment, Net | 0 | USD | -100% |
| Assets | 22.4K | USD | -64.1% |
| Accounts Payable, Current | 311K | USD | -15.9% |
| Accrued Liabilities, Current | 6.71K | USD | -84.2% |
| Liabilities | 931K | USD | -63.3% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | 50.5K | USD | -10.3% |
| Retained Earnings (Accumulated Deficit) | -10.4M | USD | -1.3% |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | -909K | USD | +63.2% |
| Liabilities and Equity | 22.4K | USD | -64.1% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Net Cash Provided by (Used in) Operating Activities | -22.9K | USD | +43.2% |
| Net Cash Provided by (Used in) Financing Activities | 0 | USD | -100% |
| Common Stock, Shares Authorized | 7.5B | shares | +2400% |
| Common Stock, Shares, Issued | 297M | shares | +372% |
| Common Stock, Par or Stated Value Per Share | 0 | USD/shares | 0% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | -22.9K | USD | +43.2% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | 20.6K | USD | -64.6% |
| Deferred Tax Assets, Valuation Allowance | 1.88M | USD | +0.81% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | -138K | USD | +62.3% |
| Additional Paid in Capital | 8.74M | USD | +20.2% |
| Deferred Tax Assets, Net of Valuation Allowance | 0 | USD | |
| Interest Expense | 44.6K | USD | -29.9% |